Literature DB >> 15584925

STAT6 transcription factor binding sites with mismatches within the canonical 5'-TTC...GAA-3' motif involved in regulation of delta- and mu-opioid receptors.

Christine Börner1, Michael Wöltje, Volker Höllt, Jürgen Kraus.   

Abstract

Opioid receptors are expressed in neuronal and immune cells and regulated in response to immunological processes. Herein, we demonstrate up-regulation of the delta-opioid receptor gene by interleukin-4 in immune cells (primary T and polymorphonuclear leukocytes, Jurkat E6 T cells), and in NG 108-15 neuronal cells. We identified an interleukin-4-responsive element at nt -671 on the murine gene promoter, to which the transcription factor STAT6 binds, as shown by reporter gene analysis and STAT6/DNA interaction studies in living cells with transcription factor decoy oligonucleotides. STAT6 normally binds to palindromic DNA motifs with a 5'-TTC...GAA-3' core. Notably, the delta-opioid receptor STAT6 site (5'-TTC...GGA-3') is an imperfect palindrome with a mismatch within this core sequence. A systematic analysis of possible mismatch 5'-TTC...GAA-3' motifs revealed that STAT6 also binds to the sequence 5'-TTA...GAA-3'. This motif occurs as a polymorphism in the human mu-opioid receptor gene (Kraus et al. 2001 J. Biol. Chem 276, 43901-43908). We show that this mutated element has a significantly reduced STAT6 binding activity which correlates to its reduced interleukin (IL)-4 inducibility. In contrast, the non-canonical STAT6 site of the delta-opioid receptor binds STAT6 with similar high activity as a perfectly palindromic STAT6 site and is strongly inducible by IL-4.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15584925     DOI: 10.1111/j.1471-4159.2004.02846.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

Review 1.  Transcriptional and epigenetic regulation of opioid receptor genes: present and future.

Authors:  Li-Na Wei; Horace H Loh
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011       Impact factor: 13.820

Review 2.  "Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Erin D Milligan; Steven F Maier
Journal:  Brain Res Rev       Date:  2007-07-13

Review 3.  Mode of action of cytokines on nociceptive neurons.

Authors:  Nurcan Uçeyler; Maria Schäfers; Claudia Sommer
Journal:  Exp Brain Res       Date:  2009-03-17       Impact factor: 1.972

Review 4.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

5.  T-lymphocyte-derived enkephalins reduce Th1/Th17 colitis and associated pain in mice.

Authors:  Lilian Basso; Laure Garnier; Arnaud Bessac; Jérôme Boué; Catherine Blanpied; Nicolas Cenac; Sophie Laffont; Gilles Dietrich
Journal:  J Gastroenterol       Date:  2017-04-19       Impact factor: 7.527

Review 6.  IL-4, JAK-STAT signaling, and pain.

Authors:  Melanie Busch-Dienstfertig; Sara González-Rodríguez
Journal:  JAKSTAT       Date:  2014-01-02

Review 7.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

8.  Inducible expression of functional mu opioid receptors in murine dendritic cells.

Authors:  Zheng-Hong Li; Niansheng Chu; Li-Dong Shan; Shan Gong; Qi-Zhang Yin; Xing-Hong Jiang
Journal:  J Neuroimmune Pharmacol       Date:  2009-02-03       Impact factor: 4.147

9.  Influence of comorbidity with depression on interdisciplinary therapy: outcomes in patients with chronic low back pain.

Authors:  Haili Wang; Carsten Ahrens; Winfried Rief; Marcus Schiltenwolf
Journal:  Arthritis Res Ther       Date:  2010-10-11       Impact factor: 5.156

Review 10.  Status of immune mediators in fibromyalgia.

Authors:  Ali Gur; Pelin Oktayoglu
Journal:  Curr Pain Headache Rep       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.